Browse > Article

Distribution of Quinolones (Ciprofloxacin, Norfloxacin and Oxolinic acid) after Oral Administration in Carp (Cyprinus carpio)  

Choi, Min-Soon (Department of Aqualife Medicine, Kunsan National University)
Park, Kwan-Ha (Department of Aqualife Medicine, Kunsan National University)
Publication Information
Journal of fish pathology / v.18, no.3, 2005 , pp. 269-276 More about this Journal
Abstract
The concentrations of quinolones (oxolinic acid; OXA, norlloxacin: NRF & ciprofloxacin: CPF) after oral administration of single doses (20 mg/kg B.W.) were investigated in carp (Cyprinus carpio) kept in freshwater at 20-23$^{\circ}C$. The distribution of the drug was studied after treatment. At points timed, from 1 h to 96 hrs after administration, blood (B), liver (L), kidney (K) and muscle (M) from 5 individuals in each group were collected for analyse with microbiological bioassay method. The peak concentrations were measured at 8 h (L), 12 h (B and K) and 24 h (M) after administration regardless of treated drugs. Considerably high concentrations of CPF (13.8-19.6${\mu}g/m{\ell}$) NRF (11.8-16.9${\mu}g/m{\ell}$) and OXA (10.8-13.9 ${\mu}g/m{\ell}$) were revealed during the 24 h. At the last time point of the experiment (96 h), concentrations of all three quinolones were: OXA, 2.3-6.3 ${\mu}g/m{\ell}$ ; NRF, 3.1-4.5 ${\mu}g/m{\ell}$ ; CPF, 3.0-5.5${\mu}g/m{\ell}$ in samples. The concentrations decreased subsequently, indicating a first rapid redistribution, followed by a slow phase of elimination. The steady state was observed in blood (12-36 h), liver (12-96 h) and muscle (36-96 h) after the initiation of treatment with OXA. Concerning the compartmental concentrations, (L, K. and M/B concentration ratio), the fluctuation of the ratio was founded at different time points, among drugs. For CPF, highest tissue ratios were prolonged in the order of L>K>M (0.65-1.2/0.82-0.93/1.0-1.7) during the experiments. On the other hand, NRF presented L>K>M (0.65-1.3/0.86-1.0) till 24 h, but L>M>K (0.89-1.26) at 36-96 h. OXA showed L>K>M (0.95-2.1) at 1-8 h, M>K>L (0.51-1.0) at 12-36 hand M>L>K (1.0-2.3) at 48-96 h, respectively.
Keywords
Quinolones; Concentration ratio; Maximal concentration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Rocca, G. D., Salvo, A. D., Malvis, J. and Sello, M.: The distribution of enrotloxacin in seabream after single intravenous injection or from medicated feed administration. Aquaculture, 232: 53-62, 2004   DOI   ScienceOn
2 Smith, J. T. and Lewin, C. S.: Chemistry and mechanicals of action of the quinolones antibacterial. In 'The Quinolones'(ed by Andriole, V. T). Academic press, London, pp. 23-82, 1988
3 Wolfson, J. S. and Hooper, D. C.: The tluroquinolones: Structures, mechanism of action and resistance, and spectra of activity in vitro. Antimicrob. Agents Chemother., 28(4): 1647-1650,1985
4 Lewin, C. S., Allen, R. A. and Amyes, G. G. B.: Potential mechanism of resistance to modern tluoroquinated 4-quinolone. J. Med. microbiol., 31: 153-161, 1990   DOI   PUBMED
5 정승희, 지보영, 이주석, 도정환, 최동림, 김진우, 박미선: 어류질병 진단 및 치료대책, 해수부, pp, 110-118. 2000
6 Stoffregen, D. A., Wooster, G. A., Bustos, P. S., Bowser, P. R. and Babish, J. G.: Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon. J. Vet. Pharmacol. Ther., 20: 111-123, 1997   DOI   ScienceOn
7 Barnes, A. C, Amyes S. G. B., Hasting, T. S. and Lewin C. S.: Fiuroquinolones display rapid bactericidal activity and low mutation frequency against Aeromonas salmonicida. J. Fish Dis., 14: 661-667,1991   DOI
8 Samuelsen, O. B., Ervik, A., Pursell, L. and Smith, P.: Single dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, In Atlantic salmon (Salmo salarv held in seawater and in vitro antibacterial activity againstA. salmonicida. Aquaculture, 18: 213-224, 2000
9 Barnes, A. C., Lewins, T. S, Hastings, T. S. and Arnyes, S. G.: In vitro activities of 4- quinolones against the fish pathogen Aeromonas sul monicida. Antimicrob. Agents Chernother., 34: 1819-1820, 1990   DOI   ScienceOn
10 Choi, M. S., Kim, K. H., Seo, Y .H., Choi, S. H. and Park, K. H.: Antibacterial activity of new quinolones against Edwardsiella tarda isolated from eel tanks. J. Fish Pathol., 9(2): 185-193, 1996
11 Stamm, J. M.: In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and saratloxacin (A-56620). J. Aquat. Anim, Health, 1: 135-141,1989   DOI
12 Hae, G. J., Park, S. C. and Kim, D. W.: A study on efficacy and safety of quinolone antibacterial (Ciprotloxacin) to bacterial disease in cultured fish, Cyprinus carpio and Oncorhynchus mykiss. Kor. J. Vet. Publ. Health, 22(2): 176-186, 1998
13 Martinsen, B. Horsberg, T E and Burke, M.: Multiple-dose pharmacokinetic and depletion studies of saratloxsacin in Atlantic salmon (Salmo salar L). J. Fish Dis., 17: 111-121. 1994   DOI   ScienceOn
14 Ellingen, O. F, Midttun, B., Rogstad, A., Syversten, C. and samuelsen O. B.: Dosage regime experiments with oxolinic acid and flumequine in Atlantic salmon(Salmo salar) held in sea water. Aquaculture, 209: 19-34, 2002   DOI   ScienceOn
15 Lewin, C. S. and Hastings, T S.: In vitro activities of oxolinic acid, ciprofloxacin and nortloxacin against of the A. saltnonicida. J. Fish Dis., 13: 377-384,1990   DOI
16 Kim J. W., lung, S. H., Lee, J. S., Choi, D. L., and Jo, M. R.: Effects of temperature on the pharmacokinetics of norfloxacin in Carp (Cyprinus carpio) and Eel (Anguilla japonica).J. Fish Pathol., 15(2): 49-56, 2002
17 Intorre, L., Ceechini, S., Cognetti- Varriale, A. M., Soldani, G. and Mengozzi, G.: Pharmacokinetics of enrotloxacin in the seabass (Dicentrarchus labraxi. Aquaculture, 182: 49-59, 2000   DOI   ScienceOn
18 Nouws, J. F. M., Grondel, J. L., Schutte, A. R. and Laurenseri, J.: Pharmacokinetics of ciprotloxacin in carp, African carp and R. trout. Vet. Quart., 10(3): 211-216, 1998
19 Alderman, D. J.: Fisheries chemotheraphy: a review, In 'recent advances in aquaculture'(ed by J. M. Muir and Roberts R. J.) Croom Helm. London, 3: 1-61. 1988
20 Rogstad, A., Ellingsen, O. F. and Syversten, C.: Pharmacokinetics and bioavailability of flumequin and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture, 110: 207-220, 1993   DOI
21 Treves, B. K. M.: Applied Fish Pharmacology. Kluwer academic pub., pp. 56-63,2000
22 Waterworth, P. M.: Quantitative methods for bacterial sensitivity testing. In review, D. S., Philips, I., Williams, J. D. Wise, R. (eds), Laboratory methods in antimicrobial chemotherapy. Livinstone, Edinburgh, pp. 31-40, 1978
23 Martinsen, B., Myhr, E, Reed, E and Hasten, T: In vitro antimicrobial activity of sarafloxacin against clinical isolates of bacteria pathogenic to fish. J. Aquat. Anim. Health, 3: 235-241, 1991   DOI
24 Ishida, N.: Tissue levels of oxolinic acid after oral or intravascular administration to fresh water and seawater rainbow trout. Aquaculture, 102: 9-15,1992   DOI   ScienceOn